H. Andreini

发表

The incidence of transition zone prostate cancer diagnosed by transperineal template-guided mapping biopsy: implications for treatment planning.

W. Butler, G. Merrick, Z. Allen, 2011, Urology.

Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB.

K. Wallner, W. Butler, G. Merrick, 2009, Urology.

Diagnostic Performance of Initial Transperineal Template-guided Mapping Biopsy of the Prostate Gland

W. Butler, G. Merrick, E. Adamovich, 2015, American journal of clinical oncology.

Transperineal Template-guided Mapping Biopsy as a Staging Procedure to Select Patients Best Suited for Active Surveillance

W. Butler, G. Merrick, R. Galbreath, 2013, American journal of clinical oncology.

Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy.

K. Wallner, W. Butler, G. Merrick, 2006, European urology.

The morbidity of transperineal template‐guided prostate mapping biopsy

K. Wallner, W. Butler, G. Merrick, 2008, BJU international.

Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting

K. Wallner, W. Butler, G. Merrick, 2009, Prostate Cancer and Prostatic Diseases.

Epididymitis after transrectal ultrasound-guided needle biopsy of prostate gland.

W. Butler, G. Merrick, Z. Allen, 2004, Urology.

Obesity does not correlate with adverse pathologic findings on transperineal template-guided mapping biopsy of the prostate.

K. Wallner, W. Butler, G. Merrick, 2011, Urologic oncology.